ARPA-H Heart Engineered Autonomous Lifesaving Recoveries (HEALR)
Funds United States health pioneers with autonomous systems research for life-critical recovery.
ARPA-H's Heart Engineered Autonomous Lifesaving Recoveries, or HEALR, is a heart-failure program aimed at engineered recovery technologies. It sits under the Advanced Research Projects Agency for Health and points at cardiac engineering rather than broad cardiovascular screening. The program offers grants from $500k to $30m, with a median actual award of $3m, and it is marked as a one-off cycle. Eligibility is limited to U.S.-based for-profit companies; nonprofits and individuals are not eligible. The technical window runs from TRL 3-7, with a 50% founder-citizenship threshold and no stacking on the same scope. HEALR is built for teams that can turn a cardiac intervention into a clinically credible recovery system with enough engineering maturity to justify ARPA-H scale funding. The strongest cases are likely to pair a clear heart-failure use case with a system that can operate autonomously enough to change outcomes rather than simply assist care, especially when the engineering plan is explicit and testable.
No upcoming rounds verified. Cadence: One-off.